Clinical Portal View

The Clinical Portal View showcases how AI integration enhances the medical records integration feature and focuses on displaying unified patient data from multiple systems while highlighting the AI capabilities.

AI Clinical Assistant
- A conversational interface that allows clinicians to ask natural language questions about the patient's health data across all connected systems. The AI responds with specific information and cites the source systems.
AI Clinical Insights
- An intelligent analysis section that identifies three key observations from analyzing data across all connected systems, categorized by priority level (high priority, monitoring needed, positive trend).
AI Lab Interpretation
- Automated analysis of lab results that provides plain-language interpretations of trends and abnormalities.
Intelligent Timeline
- A chronological view of patient events from multiple sources, presented in a unified, easy-to-read format.
Medication Adherence Analysis
- AI-detected patterns in medication usage, highlighting potential adherence issues.
The page emphasizes:
- Data sovereignty (all processing happens on-premises)
- Clear source attribution (each piece of information shows which system it came from)
- Integration of data from multiple systems (Epic, AGFA PACS, LabCorp, etc.)
- Natural language interaction with medical data
- Automatic detection of concerning patterns and trends

This interface would allow clinicians to see a complete picture of the patient across all connected systems, with AI assistance to help identify important patterns and retrieve specific information quickly.

Back Request a Demo

Clinical Portal View - FluxAI Healthcare Demo

Open in New Window

FluxAI

ENTERPRISE

Dr. Sarah Johnson

Robert Thompson

58 years (04/15/1967)

Male

MRN: 78952413

(555) 123-4567

Patient has medication allergies: Penicillin, Sulfa drugs

AI detected potential interaction with current medications. View details

AI Clinical Assistant

Active

Ask me questions about Robert's medical history, lab results, or treatment options.

What is the patient's most recent A1C?

Robert's most recent A1C was 7.2% from 3/15/2025 (36 days ago), showing improvement from 8.1% on 12/10/2024.

Source: LabCorp View Full Report

Are there any concerning trends in his cardiac function?

Analysis of cardiac data shows a 12% reduction in ejection fraction over 6 months (58% → 51%). Also noted irregular heart rate patterns in 3 recent ECGs.

Recommendation: Consider cardiology consult.

Sources: Epic, AGFA PACS View Details

Clinical Timeline

Emergency Room Visit

04/02/2025

Chest pain and shortness of breath. Cardiac enzymes negative. EKG showed sinus tachycardia.

Source: Memorial Hospital

Cardiology Consultation

03/15/2025

Stress echocardiogram performed. Ejection fraction 51%. Recommendation to adjust beta blocker dosage.

Source: Downtown Cardiology

Primary Care Visit

03/15/2025

Routine diabetes follow-up. A1C improved to 7.2%. Blood pressure 138/85.

Source: Family Health Associates

Laboratory Tests

03/15/2025

Comprehensive metabolic panel, lipid panel, and A1C. Elevated triglycerides (210 mg/dL).

Source: LabCorp

Prescription Updated

03/15/2025

Metformin increased to 1000mg BID. Lisinopril continued at 20mg daily.

Source: Family Health Associates

AI Clinical Insights

3 key observations from analyzing data across all connected systems

High Priority

Declining cardiac function detected across multiple visits. 12% reduction in ejection fraction in 6 months.

Sources: 3 systems

Monitoring Needed

Medication adherence patterns suggest possible gaps in Beta Blocker administration (72% adherence).

Sources: 2 systems

Positive Trend

Diabetes management improving. A1C trending down over 3 months from 8.1% to 7.2%.

Sources: 2 systems

Active Problems

Data from 3 systems

Problem	Status	Onset	Source
Type 2 Diabetes Mellitus E11.9	Controlled	08/2019	Family Health Associates
Essential Hypertension I10	Controlled	05/2018	Family Health Associates
Coronary Artery Disease I25.10	Worsening	11/2022	Downtown Cardiology
Hyperlipidemia E78.5	Controlled	05/2018	Family Health Associates

Current Medications

Data from 2 systems

Metformin

Diabetes

1000mg, Twice daily

Prescribed: 03/15/2025 | Dr. James Wilson

95% adherence rate

Lisinopril

Hypertension

20mg, Once daily

Prescribed: 03/15/2025 | Dr. James Wilson

92% adherence rate

Atorvastatin

Cholesterol

40mg, Once daily at bedtime

Prescribed: 12/10/2024 | Dr. James Wilson

89% adherence rate

Metoprolol

Cardiac

25mg, Twice daily

Prescribed: 03/15/2025 | Dr. Maria Chen

72% adherence rate

AI detected possible adherence issue

Recent Lab Results

Data from LabCorp

AI Lab Interpretation Powered by DEfRAG

Analysis of the most recent labs from 03/15/2025 shows improvement in glycemic control (A1C 7.2%, down from 8.1%) but persistent dyslipidemia with elevated triglycerides (210 mg/dL) despite statin therapy. Kidney function remains stable with estimated GFR of 75 mL/min.

Test	Value	Reference	Previous	Change
Hemoglobin A1C 03/15/2025	7.2%	4.0 - 5.6%	8.1% (12/10/2024)	0.9%
LDL Cholesterol 03/15/2025	118 mg/dL	< 100 mg/dL	125 mg/dL (12/10/2024)	7 mg/dL
Triglycerides 03/15/2025	210 mg/dL	< 150 mg/dL	195 mg/dL (12/10/2024)	15 mg/dL
eGFR 03/15/2025	75 mL/min	≥ 60 mL/min	73 mL/min (12/10/2024)	2 mL/min

Previous: System Analytics & Reporting Next: Connector Setup Wizard

Clinical Portal View

FluxAI

Robert Thompson

AI Clinical Assistant

Clinical Timeline

AI Clinical Insights

High Priority

Monitoring Needed

Positive Trend

Active Problems

Current Medications

Metformin

Lisinopril

Atorvastatin

Metoprolol

Recent Lab Results

More Features in this Concept

Related Solutions